JENNIFER STANLEY: Open Payments
NPI 1467682450 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,192 in 37 payments from 17 companies in 2025. Trend: 2023 $790 · 2024 $736 · 2025 $1,192
Food & beverage: $1,192
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $329 |
| Eisai Inc. | 2 | $139 |
| Lilly USA, LLC | 1 | $122 |
| Amgen Inc. | 6 | $117 |
| Novo Nordisk Inc | 4 | $93 |
| PFIZER INC. | 3 | $59 |
| Verastem, Inc. | 2 | $50 |
| AstraZeneca Pharmaceuticals LP | 3 | $47 |
| GlaxoSmithKline, LLC. | 2 | $44 |
| Phathom Pharmaceuticals, Inc. | 2 | $43 |
Products named: VRAYLAR, QULIPTA, ZEPBOUND, Leqembi, OTEZLA, Ozempic, AVMAPKI FAKZYNJA CO-PACK, FARXIGA.
Industry payments across FL — which companies pay providers there.
